Advancing Blood Disease Research in China

The Institute of Hematology & Blood Diseases Hospital (IHBDH) plans to develop the National Longitudinal Cohort of Hematological Diseases (NICHE), China’s first prospective longitudinal national multi-disease cohort of patients with blood diseases. The cohort will initially include patients with leukemia, lymphoma, myelodysplastic syndromes, multiple myeloma, hemophilia, and various pediatric hematologic malignancies. The data from this project will be used to develop a generalizable research model to advance blood disease research in China. Analysis Group is working closely with IHBDH to facilitate the design and implementation of the research platform, and to co-organize the scientific advisory committee.

Analysis Group Logo

Analysis Group Beijing

No.2 Jianguomenwai Avenue
Unit 3101, L31, Yintai Office Tower C
Chaoyang, Beijing, 100022

Tel: 86 10 6587 6200
Fax: 86 10 6587 6201


Institute of Hematology & Blood Diseases Hospital (IHBDH)

288 Nanjing Road
Heping District, Tianjin 300020